Skip to main content
. Author manuscript; available in PMC: 2025 Jun 1.
Published in final edited form as: Surv Ophthalmol. 2025 Jan 14;70(3):499–515. doi: 10.1016/j.survophthal.2025.01.003

Table 7. Changes in corneal fluorescein score following exosomes treatment.

Study DED model type and
treatment route
DED treated with
Exosomes
DED given
PBS/saline
Absolute difference between
PBS group and exosomes
Healthy
control
Absolute difference between
exosome and healthy control
Tian et al.
2023 *
C57BL/6 mice BAC model, topical MSC-Exo; 6MSC-Exo-
Ce; 2
12.5 10.5−6.5 0.5 1.5−5.5
Ma
et al.2023 *
C57BL/6 mice BAC model, topical mExo; 7.5mExo@AA;
4
15 7.5−11 1 3−6.5
Wang et al.
2022*
C57BL/6 mice BAC model, topical 1.8 3.5 1.7 0.5 1.3
Guo et al.
2022 *
C57BL/6 mice BAC model, topical 3 5 2 0.5 2.5
Wang
et al.2023 *
C57BL/6 mice BAC model, topical 2 in 3.0 mg/mL Exo group 8 6 N/A
Yu et al.2020 C57BL/6 mice BAC model, topical 5.2 12.0 6.8 1.2 4
*

Values obtained from the graph as no absolute values given in the article

DED- Dry Eye Disease, PBS − Phosphate Buffer Solution, BAC − Benzalkonium Chloride, MSC − Mesenchymal Stem Cell